Proteomics & Atturos partner to target diagnostics in Europe
Filed with ASX · · 2 pages · English
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Proteomics to receive $928k from sale of shareholding in CPR
- Diagnostics update- Pipeline yields potential new biomarkers
- Appendix 4C - June 2018 Quarterly Report
- Proteomics secures major contract - nears cash flow positive
- Further information on new licence deals in USA and Mexico
Later from Proteomics International Laboratories
- Proteomics receives $834k in R&D Tax Incentive
- Diabetic kidney disease test enters Europe & Export Award
- Appendix 4C - September 2018 Quarterly Report
- PromarkerD kit version complete- commercial release imminent
- Proteomics signs PromarkerD agreement with US big pharma
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories